FR2276832A1 - Nouvelles compositions pharmaceutiques et leur preparation - Google Patents
Nouvelles compositions pharmaceutiques et leur preparationInfo
- Publication number
- FR2276832A1 FR2276832A1 FR7520946A FR7520946A FR2276832A1 FR 2276832 A1 FR2276832 A1 FR 2276832A1 FR 7520946 A FR7520946 A FR 7520946A FR 7520946 A FR7520946 A FR 7520946A FR 2276832 A1 FR2276832 A1 FR 2276832A1
- Authority
- FR
- France
- Prior art keywords
- preparation
- pharmaceutical compositions
- new pharmaceutical
- new
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH931274 | 1974-07-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2276832A1 true FR2276832A1 (fr) | 1976-01-30 |
FR2276832B1 FR2276832B1 (ja) | 1978-10-06 |
Family
ID=4350618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7520946A Granted FR2276832A1 (fr) | 1974-07-05 | 1975-07-03 | Nouvelles compositions pharmaceutiques et leur preparation |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPS5132724A (ja) |
AU (1) | AU8280175A (ja) |
BE (1) | BE831042A (ja) |
DE (1) | DE2528516A1 (ja) |
ES (1) | ES439113A1 (ja) |
FR (1) | FR2276832A1 (ja) |
GB (1) | GB1518683A (ja) |
HU (1) | HU170215B (ja) |
IL (1) | IL47634A (ja) |
NL (1) | NL7507798A (ja) |
NZ (1) | NZ178011A (ja) |
SE (1) | SE7507414L (ja) |
YU (1) | YU170475A (ja) |
ZA (1) | ZA754304B (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0041030A1 (fr) * | 1980-05-28 | 1981-12-02 | Pierre Fabre S.A. | Compositions à usage topique contenant des alcaloides de l'ergot de seigle et de vinca rosea destinés au traitement des hyperséborrhées, ainsi que leur préparation |
FR2548025A1 (fr) * | 1983-07-01 | 1985-01-04 | Nitto Electric Ind Co | Excipient comprenant un adjuvant alcoolique et un solvant pour l'administration percutanee d'un agent a activite physiologique |
EP0279986A1 (en) * | 1987-02-26 | 1988-08-31 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolaurate |
EP0295411A1 (en) * | 1987-05-15 | 1988-12-21 | Sansho Co., Ltd. | Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or a salt thereof |
EP0521799A1 (en) * | 1991-07-05 | 1993-01-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Ophthalmic compositions |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54163810A (en) * | 1978-06-14 | 1979-12-26 | Mundipharma Ag | Gel composition for local coating |
JPS56159310A (en) * | 1980-05-14 | 1981-12-08 | Showa Denko Kk | Preparation of monofilament having high strength and knot strength |
JPS59216825A (ja) * | 1983-05-23 | 1984-12-06 | Takeda Chem Ind Ltd | 経皮吸収外用製剤 |
US5128376A (en) * | 1983-07-01 | 1992-07-07 | Nitto Denko Corporation | Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator |
US4752612A (en) * | 1983-07-01 | 1988-06-21 | Nitto Electrical Industrial Co., Ltd. | Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent |
JPS6013720A (ja) * | 1983-07-01 | 1985-01-24 | Nitto Electric Ind Co Ltd | 生理的活性剤の吸収促進剤 |
US4751087A (en) * | 1985-04-19 | 1988-06-14 | Riker Laboratories, Inc. | Transdermal nitroglycerin delivery system |
JPH0735331B2 (ja) * | 1986-01-16 | 1995-04-19 | 久光製薬株式会社 | 外用ゲル製剤 |
JPH0735332B2 (ja) * | 1986-02-25 | 1995-04-19 | 久光製薬株式会社 | 外用クリ−ム製剤 |
JPH0759519B2 (ja) * | 1987-02-23 | 1995-06-28 | 株式会社資生堂 | 経皮吸収促進剤及びこれを含有する皮膚外用製剤 |
DE3710216A1 (de) * | 1987-03-27 | 1988-10-06 | Rentschler Arzneimittel | Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen |
US5223261A (en) * | 1988-02-26 | 1993-06-29 | Riker Laboratories, Inc. | Transdermal estradiol delivery system |
CH679119A5 (ja) * | 1988-05-13 | 1991-12-31 | Sandoz Ag | |
GB2230444B (en) * | 1989-04-19 | 1993-12-08 | Ritchie Swanson John | Therapeutic compositions. |
US5219877A (en) * | 1989-09-25 | 1993-06-15 | Bristol-Myers Squibb Company | Lauryl alcohol as skin penetration enhancer for topical imidazole agents |
US5397771A (en) * | 1990-05-10 | 1995-03-14 | Bechgaard International Research And Development A/S | Pharmaceutical preparation |
WO1991016929A1 (en) * | 1990-05-10 | 1991-11-14 | Novo Nordisk A/S | A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols |
US5681852A (en) * | 1993-11-12 | 1997-10-28 | The Procter & Gamble Company | Desquamation compositions |
ES2171522T3 (es) * | 1993-11-12 | 2002-09-16 | Procter & Gamble | Composiciones de desescamacion que contienen acido salicilico y compuestos bipolares. |
US5821237A (en) * | 1995-06-07 | 1998-10-13 | The Procter & Gamble Company | Compositions for visually improving skin |
US6005135A (en) * | 1996-03-21 | 1999-12-21 | Exxon Chemical Patents Inc. | Water-borne polymeric vehicle for coating compositions containing an amine or ammonium salt of phenolic ester alcohols |
US6096326A (en) * | 1997-08-15 | 2000-08-01 | Scandinavian-American Import/Export Corporation | Skin care compositions and use |
US7258869B1 (en) | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
WO2000045790A2 (en) † | 1999-02-08 | 2000-08-10 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
AU2007266475B2 (en) | 2006-05-30 | 2009-12-03 | Intarcia Therapeutics, Inc. | Two-piece, internal-channel osmotic delivery system flow modulator |
NZ574524A (en) | 2006-08-09 | 2011-07-29 | Intarcia Therapeutics Inc | Piston assembly for positioning lumen of a reservoir for an osmotic delivery having a columnar body and a spring |
AU2008244523B2 (en) | 2007-04-23 | 2012-02-16 | Intarcia Therapeutics, Inc. | Suspension formulations of insulinotropic peptides and uses thereof |
US8623387B2 (en) | 2007-11-22 | 2014-01-07 | Medrx Co., Ltd. | External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
CA2726861C (en) | 2008-02-13 | 2014-05-27 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
WO2011037623A1 (en) | 2009-09-28 | 2011-03-31 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery |
JP2012020991A (ja) | 2010-06-16 | 2012-02-02 | Takasago Internatl Corp | 経皮吸収促進剤、及びこれを含有する皮膚外用製剤 |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
JP5820207B2 (ja) * | 2011-09-13 | 2015-11-24 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
JP5820206B2 (ja) | 2011-09-13 | 2015-11-24 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
JP6482570B2 (ja) | 2014-10-30 | 2019-03-13 | 旭化成株式会社 | 経皮吸収促進剤及び経皮吸収促進助剤 |
EP3302354B1 (en) | 2015-06-03 | 2023-10-04 | i2o Therapeutics, Inc. | Implant placement systems |
AU2017268161B2 (en) | 2016-05-16 | 2020-03-12 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
CA3049034A1 (en) | 2017-01-03 | 2018-07-12 | Intarcia Therapeutics, Inc. | Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug |
-
1975
- 1975-06-26 DE DE19752528516 patent/DE2528516A1/de active Pending
- 1975-06-27 SE SE7507414A patent/SE7507414L/xx unknown
- 1975-07-01 NL NL7507798A patent/NL7507798A/xx unknown
- 1975-07-02 YU YU01704/75A patent/YU170475A/xx unknown
- 1975-07-03 HU HUSA2816A patent/HU170215B/hu unknown
- 1975-07-03 ES ES439113A patent/ES439113A1/es not_active Expired
- 1975-07-03 IL IL47634A patent/IL47634A/xx unknown
- 1975-07-03 NZ NZ178011A patent/NZ178011A/xx unknown
- 1975-07-03 FR FR7520946A patent/FR2276832A1/fr active Granted
- 1975-07-04 BE BE158022A patent/BE831042A/xx unknown
- 1975-07-04 JP JP50082022A patent/JPS5132724A/ja active Pending
- 1975-07-04 ZA ZA754304A patent/ZA754304B/xx unknown
- 1975-07-04 GB GB28246/75A patent/GB1518683A/en not_active Expired
- 1975-07-07 AU AU82801/75A patent/AU8280175A/en not_active Expired
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0041030A1 (fr) * | 1980-05-28 | 1981-12-02 | Pierre Fabre S.A. | Compositions à usage topique contenant des alcaloides de l'ergot de seigle et de vinca rosea destinés au traitement des hyperséborrhées, ainsi que leur préparation |
FR2483235A1 (fr) * | 1980-05-28 | 1981-12-04 | Fabre Sa Pierre | Compositions a usage topique contenant des alcaloides de l'ergot de seigle et de vinca rosea destinees au traitement des hyperseborrhees |
FR2548025A1 (fr) * | 1983-07-01 | 1985-01-04 | Nitto Electric Ind Co | Excipient comprenant un adjuvant alcoolique et un solvant pour l'administration percutanee d'un agent a activite physiologique |
EP0279986A1 (en) * | 1987-02-26 | 1988-08-31 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolaurate |
EP0295411A1 (en) * | 1987-05-15 | 1988-12-21 | Sansho Co., Ltd. | Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or a salt thereof |
EP0521799A1 (en) * | 1991-07-05 | 1993-01-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Ophthalmic compositions |
Also Published As
Publication number | Publication date |
---|---|
ZA754304B (en) | 1977-02-23 |
ES439113A1 (es) | 1977-10-16 |
NZ178011A (en) | 1978-07-28 |
AU8280175A (en) | 1977-01-13 |
DE2528516A1 (de) | 1976-01-22 |
NL7507798A (nl) | 1976-01-07 |
GB1518683A (en) | 1978-07-19 |
IL47634A (en) | 1978-07-31 |
YU170475A (en) | 1984-02-29 |
BE831042A (fr) | 1976-01-05 |
IL47634A0 (en) | 1975-10-15 |
HU170215B (ja) | 1977-04-28 |
FR2276832B1 (ja) | 1978-10-06 |
SE7507414L (sv) | 1976-01-07 |
JPS5132724A (ja) | 1976-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2276832A1 (fr) | Nouvelles compositions pharmaceutiques et leur preparation | |
BE810197A (fr) | Nouvelles electrodes et leur preparation | |
BE833044A (fr) | 4-arylpiperidines 1, 3, 4 -trisubtituees et leur preparation | |
FR2327764A1 (fr) | Nouvelles compositions pharmaceutiques et leur preparation | |
FR2285891A1 (fr) | Nouvelles benzodiazepines et leur preparation | |
BE832860A (fr) | Benzo-isoquinoleine-diones et leur preparation | |
BE833586A (fr) | Aminobenzazocines et leur preparation | |
BE832921A (fr) | Nouvelles rifamycines et leur preparation | |
BE829082A (fr) | Nouvelles diamines, leur preparation et leur application | |
BE825982A (fr) | Triazoloquinazolines et leur preparation | |
FR2283689A1 (fr) | Nouvelles cephamycines, leur preparation et leur application | |
FR2290193A1 (fr) | Derives de n2-naphtalenesulfonyl-l-arginine, leur preparation et compositions pharmaceutiques les contenant | |
FR2276833A1 (fr) | Nouvelles compositions galeniques et leur preparation | |
FR2275207A1 (fr) | Nouvelles benzylamines leur preparation et les compositions pharmaceutiques en contenant | |
BE831743A (fr) | Nouvelles substances antibiotiques et leur preparation | |
FR2313059A1 (fr) | Nouvelles solutions pharmaceutiques stables et leur preparation | |
FR2274291A1 (fr) | Nouvelles compositions pharmaceutiques et procede pour leur preparation | |
BE826925A (fr) | Nouvelles pyrrolodiazepines et leur preparation | |
BE820256A (fr) | Nouvelles phenoxyalkylamines et leur preparation | |
BE840608A (fr) | Nouvelles compositions pharmaceutiques | |
FR2287220A1 (fr) | Nouvelles compositions pharmaceutiques anti-inflammatoires et leur procede de preparation | |
FR2285871A1 (fr) | Compositions pharmaceutiques | |
BE826986A (fr) | Nouvelles benzodiazepines et leur preparation | |
BE829153A (fr) | 5-phenyl-thiazolidine-4-ones et leur preparation | |
BE832464A (fr) | 3,4-dihydro-2h-isoquinoleine-1-thiones et leur preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |